The Health Care M&A Monthly: March Merger Mania in Pharma
Europe Sees A Flurry of Springtime Dealmaking In The Pharmaceutical Industry, As Bayer Leads The Pack With A $19.5 Billion Bid for Schering AG March saw a surge of M&A activity in the pharmaceutical sector, particularly in Europe. A total of 17 deals were...The SeniorCare Investor: Hearthstone Announces Sale–
Nationwide Health Properties Is The Surprise Winner After months of speculation, with many rumors about some very high preliminary pricing levels, a deal was finally struck for the Hearthstone Assisted Living portfolio. Most of the major players looked at the...The Health Care M&A Monthly: Extendicare To Explore Strategic Alternatives –
Possible $2 Billion Breakup and Sale of Extendicare May Help Jumpstart Skilled Nursing M&A Market in 2006 Two paragraphs into its otherwise routine fourth-quarter and year-end earnings report, Extendicare (NYSE: EXE) revealed that it had engaged Lehman Brothers...The SeniorCare Investor: Assisted Living and Independent Living Prices Soared in 2005
The year 2005 will go down in senior care market history if not as the most memorable, then certainly as the most bountiful. Across the board, many records were set in the 2005 seniors housing acquisition market, which includes both assisted and independent living...The Health Care M&A Monthly: To The Winners Go The Spoils… Boston Scientific’s $27 Billion Bid for Guidant Trumps Johnson & Johnson’s While Abbott Laboratories Lands Itself a Strong Vascular Business
Email Editor Knowing when to hold ‘em and knowing when to fold ‘em are useful skills in more games than just poker. The bidding war for Guidant Corporation (NYSE: GDT), raging over the past two months, has finally come to an end with Guidant’s board accepting Boston...Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
